Sharjah Announces Three New Pharmaceutical Factories Worth AED308.7 Million
|The new factories will specialise in producing respiratory products, eye drops, antibiotic capsules, stomach medications, and first aid materials.
Three new pharmaceutical factories will be established in Sharjah, with a combined investment value exceeding $84 million (AED308.7 million). The agreements for the new factories were signed during the 13th International Pharmacy and Medicine Conference (ICPM 2025), held at the Sharjah Research, Technology, and Innovation Park.
The new factories will specialise in producing respiratory products, eye drops, antibiotic capsules, stomach medications, and first aid materials. Construction is in progress, with completion anticipated between mid and late 2026. The development signals the UAE's rising role in pharmaceutical innovation and its ability to compete globally in the health sector.
With a $44 million investment, the first factory will use state-of-the-art technologies to produce eye drops and respiratory products. By the end of 2026, the construction will be finished. The second factory, with a $35 million investment in a 10,000-square-foot space, will produce antibiotic capsules and stomach medications. It will have a production capacity of 600 million capsules annually, with operations starting next year. The third factory, worth $5 million, will focus on first aid products, with construction set to commence later this year and completion expected in early 2026.